the authors report a case of fatal daunorubicin cardiotoxicity on initial phase of therapy for acute myeloblastic leukemia at cumulative doses ( 225 mg/mq ) considered still safe from the current literature .
C0011015
daunorubicin
C0023467
acute myeloblastic leukemia